EN ISO 25539-2:2009

Cardiovascular implants - Endovascular devices - Part 2: Vascular stents (ISO 25539-2:2008)

Publication date:   Aug 21, 2009

General information

99.60 Withdrawal effective   Dec 1, 2012

CEN

CEN/TC 285 Non-active surgical implants

European Norm

11.040.40   Implants for surgery, prosthetics and orthotics

Buying

  Withdrawn

PDF - €116.62

  English  



Buy

Scope

ISO 25539-2:2008 specifies requirements for vascular stents, based upon current medical knowledge. With regard to safety, it gives requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization packaging and information supplied by the manufacturer. It should be considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.
The scope of ISO 25539-2:2008 includes vascular stents used to treat vascular lesions or stenoses, or other vascular abnormalities. These devices might or might not incorporate surface modifications of the stent such as drug and/or other coatings. Stents covered with materials that significantly modify the permeability of the uncovered stent are within the scope of ISO 25539-1:2003. The stent design might dictate the need to address functional requirements identified in both ISO 25539-1:2003 and ISO 25539-2:2008.
Delivery systems are included in ISO 25539-2:2008 if they comprise an integral component of the deployment of the vascular stent.
Some pharmacological aspects of drug eluting stents are addressed in ISO 25539-2:2008, but this document is not comprehensive with respect to the pharmacological evaluation of drug eluting stents.
With the exception of sterilization, ISO 25539-2:2008 does not address requirements for the evaluation of animal tissue products.

Related legislation

Legislation related to this standard

93/42/EEC

Medical devices

Harmonized/Supporting
2007/47/EC

Directive 2007/47/EC of the European Parliament and of the council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market

Life cycle

PREVIOUSLY

WITHDRAWN
EN ISO 25539-2:2008

WITHDRAWN
EN 12006-3:1998+A1:2009

NOW

WITHDRAWN
EN ISO 25539-2:2009
99.60 Withdrawal effective
Dec 1, 2012

CORRIGENDA / AMENDMENTS

WITHDRAWN
EN ISO 25539-2:2009/AC:2011

REVISED BY

WITHDRAWN
EN ISO 25539-2:2012

Relations

Adopted from ISO 25539-2:2008 IDENTICAL